Pertussis in infants, children, and adolescents: Diagnosis, treatment, and prevention

Seminars in Pediatric Infectious Diseases

Volumn 17, Issue 1, 2006, Pages 14-19

  Munoz, Flor M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADACEL; ANTIBIOTIC AGENT; AZITHROMYCIN; BRONCHODILATING AGENT; CLARITHROMYCIN; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEMAGGLUTININ; HEPATITIS B VACCINE; IMMUNOGLOBULIN; PERTACTIN; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; STEROID;

ARTICLE; ARTIFICIAL VENTILATION; BORDETELLA PERTUSSIS; CANDIDA ALBICANS; CATHETER INFECTION; DRUG MONITORING; DRUG TOLERANCE; HUMAN; KLEBSIELLA PNEUMONIAE; LOWER RESPIRATORY TRACT INFECTION; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; OXYGEN THERAPY; PERTUSSIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION, SECONDARY; INFANT; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 33644758354     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.spid.2005.11.005     Document Type: Article

References (49)

1. Centers for Disease Control and Prevention Pertussis vaccination use of acellular pertussis vaccines among infants and young children - recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 46 1997 1 25
2. American Academy of Pediatrics CoID Recommended childhood immunization schedule United States, 2002 Pediatrics 109 2002 162 164
3. M.E. Pichichero, M.B. Rennels, K.M. Edwards Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults JAMA 293 2005 3003 3011
4. K.M. Edwards Overview of pertussis focus on epidemiology, sources of infection, and long term protection after infant vaccination Pediatr Infect Dis J 24 suppl 6 2005 S104 S108
5. E.L. Hewlett, K.M. Edwards Clinical practice. Pertussis - not just for kids (review) N Engl J Med 24 2005 1215 1222
6. J.P. Davis Clinical and economic effects of pertussis outbreaks Pediatr Infect Dis J 24 suppl 6 2005 S109 S116
7. Centers for Disease Control and Prevention Pertussis - United States, 1997-2000 MMWR 51 2002 73 76
8. F.L. Christopher, M.J. Hepburn, R.A. Frolichstein Pertussis in a military and military beneficiary population case series and review of the literature Mil Med 167 2002 215 218
9. D.M. Skowronski, G. De Serres, D. MacDonald The changing age and seasonal profile of pertussis in Canada J Infect Dis 185 2002 1448 1453
10. E. Galanis, A. King, P. Varughese The changing age and seasonal profile of pertussis in British Columbia, not Canada J Infect Dis 186 2002 1537 1538
11. S. Gilberg, E. Njamkepo, C. Du Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage J Infect Dis 186 2002 415 418
12. N.S. Crowcroft, N. Andrews, C. Rooney Deaths from pertussis are underestimated in England Arch Dis Child 86 2002 336 338
13. M. Lin, P. Roche, J. Spencer Australiar'a notifiable disease status, 2000. Annual report of the National Notifiable Diseases Surveillance System Commun Dis Intell 26 2002 118 203
14. N.M. Spearing, R.L. Horvath, J.G. McCormack Pertussis adults as a source in health care setting Med J Aust 177 2002 568 569
15. J. Wang, Y. Yang, J. Li Infantile pertussis rediscovered in China Emerg Infect Dis 8 2002 859 861
16. T.H. Hardwick, P. Cassiday, R.S. Weyant Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999 Emerg Infect Dis 8 2002 44 49
17. I.H. Van Loo, F.R. Mooi Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines Microbiology 148 2002 2011 2018
18. Centers for Disease Control and Prevention Pertussis Deaths - United States, 2002 MMWR 51 2002 616 618
19. Centers for Disease Control and Prevention Pertussis Surveillance Report - weeks 1-52, 2004 - Final data. 8-12-2005
20. M. Poynten, M. Hanlon, L. Irwig Serological diagnosis of pertussis evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection Epidemiol Infect 128 2002 161 167
21. Centers for Disease Control and Prevention Guidelines for the control of pertussis outbreaks 2000 Centers for Disease Control Atlanta, GA
22. J.L. Cloud, W. Hymas, K.C. Carroll Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture J Clin Microbiol 40 2002 3838 3840
23. F.A. Lievano, M.A. Reynolds, A.L. Waring Issues associated with and recommendations for using PCR to detect outbreaks of pertussis J Clin Microbiol 40 2002 2801 2805
24. L.M. Sloan, M.K. Hopkins, P.S. Mitchell Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens J Clin Microbiol 40 2002 96 100
25. K. Kosters, U. Reischl, J. Schmetz Real-time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis J Clin Microbiol 40 2002 1719 1722
26. J. Taranger, B. Trollfors, T. Lagergard Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis J Infect Dis 181 2000 1010 1013
27. J.D. Cherry Comparative efficacy of acellular pertussis vaccines an analysis of recent trials Pediatr Infect Dis J 16 suppl 4 1997 S90 S96
28. Centers for Disease Control and Prevention Notice to readers Food and Drug Administration Approval of Fifth Acellular Pertussis Vaccine for Use Among Infants and Young Children - United States, 2002 MMWR 51 2002 574
29. D.P. Greenberg, L.K. Pickering, S.D. Senders Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy Pediatrics 109 2002 666 672
30. S.A. Halperin, B. Smith, M. Russell Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults Pediatr Infect Dis J 19 2000 276 283
31. L.A. Jackson, B.A. Carste, D. Malais Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids Pediatr Infect Dis J 21 2002 781 786
32. Advisory Committee on Immunization Practices ACIP Recommends Adolescent Vaccination for Tetanus, Diphtheria and Pertussis Vaccine NIP Press release. 6-30-2005 2005 www.cdc.gov/nip/pr/prtdapjun2005.htm Accessed November 14, 2005
33. W.A. Keitel Cellular and acellular pertussis vaccines in adults Clin Infect Dis 28 suppl 2 1999 S118 S123
34. M.E. Pichichero, M.B. Rennels, K.M. Edwards Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults JAMA 293 2005 3003 3011 M
35. T. Tan, S. Halperin, J.D. Cherry Pertussis immunization in the global pertussis initiative North American region recommended strategies and implementation considerations Pediatr Infect Dis J 24 suppl 5 2005 S83 S86
36. S.K. Obaro, G.C. Enwere, M. Deloria Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine Pediatr Infect Dis J 21 2002 940 947
37. F. Zepp, A. Schuind, C. Meyer Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants Pediatrics 109 2002 e58
38. M. Avdicova, V. Prikazsky, H. Hudeckova Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV- IPV/Hib vaccine compared to separate concomitant injections of DTPa- IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule Eur J Pediatr 161 2002 581 587
39. D.P. Greenberg, V.K. Wong, S. Partridge Safety and immunogenicity of a combination diphtheria-tetanus toxoids- acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six months of age Pediatr Infect Dis J 21 2002 769 777
40. B.A. Halperin, S.A. Halperin, P. McGrath Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria- tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate and hepatitis B vaccines in infants from birth to six months of age Pediatr Infect Dis J 21 2002 399 405
41. M.E. Pichichero, M.M. Blatter, K.S. Reisinger Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B- inactivated poliovirus-Haemophilus influenzae type b combination vaccination Pediatr Infect Dis J 21 2002 854 859
42. M. Nicol, R. Huebner, R. Mothupi Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine a randomized trial Pediatr Infect Dis J 21 2002 138 141
43. C.M. Healy, F.M. Munoz, M.A. Rench Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum J Infect Dis 190 2004 335 340
44. T. Aoyama, K. Sunakawa, S. Iwata Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin J Pediatr 129 1996 761 764
45. M.H. Lebel, S. Mehra Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis a prospective, randomized, single blind trial Pediatr Infect Dis J 20 2001 1149 1154
46. J.M. Langley, S.A. Halperin, F.D. Boucher Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis Pediatrics 114 2004 e96 e101
47. S. Altunaiji, R. Kukuruzovic, N. Curtis Antibiotics for whooping cough (pertussis) The Cochrane Database of Systematic Reviews, 2005 Issue 1 2005 Art. No.: CD004404.pub2.DOI:10.1002/14651858.CD004404.pub2, 1-44. 1-24-2005. Available at: http://www.cochrane.org/reviews/en/ab004404.html. Accessed November 14, 2005
48. J.M. Steinberg, I. Srugo Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids Arch Pediatr Adolesc Med 156 2002 1057 1058
49. K.E. Wilson, P.K. Cassiday, T. Popovic Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance J Clin Microbiol 40 2002 2942 2944